Quinazolinone KSP inhibitors
US7671200B2 · kind B2 · utility
20Cited by
28References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 28, 2007 |
| Grant date | Mar 2, 2010 |
| Priority date | — |
| Expiry date | Jun 28, 2027 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D239/91
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Quinazolinones of formulae (a, b, c and d) are disclosed. They are useful for treating cellular proliferative diseases and disorders associated with KSP kinesin activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.